- BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
IDrugs : the investigational drugs journal (2004-01-20)
R Todd Reilly
PMID14730469
ABSTRACT
BioNumerik Pharmacology Inc, Baxter Oncology GmbH (formerly ASTA Medica AG) and Grelan Pharmaceutical Co Ltd are developing BNP-7787 for the potential reduction of toxicity associated with cisplatin and carboplatin treatment in cancer patients.
MATERIALS
Product Number
Brand
Product Description
Mesna impurity D, European Pharmacopoeia (EP) Reference Standard